SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042629
Filing Date
2021-08-09
Accepted
2021-08-09 16:08:56
Documents
82
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20210630.htm   iXBRL 10-Q 2489441
2 EX-3.4 prtk-ex34_212.htm EX-3.4 19139
3 EX-31.1 prtk-ex311_11.htm EX-31.1 18152
4 EX-31.2 prtk-ex312_6.htm EX-31.2 18314
5 EX-32.1 prtk-ex321_9.htm EX-32.1 6071
6 EX-32.2 prtk-ex322_7.htm EX-32.2 6078
  Complete submission text file 0001564590-21-042629.txt   9613106

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA prtk-20210630.xsd EX-101.SCH 78354
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20210630_cal.xml EX-101.CAL 49718
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20210630_def.xml EX-101.DEF 255867
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20210630_lab.xml EX-101.LAB 540344
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20210630_pre.xml EX-101.PRE 414622
12 EXTRACTED XBRL INSTANCE DOCUMENT prtk-10q_20210630_htm.xml XML 1771956
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 211156530
SIC: 2834 Pharmaceutical Preparations